Godavari Drugs Limited (GODAVARI) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE362C01012
Key metrics
- Market Cap
- ₹106 Cr
- P/E Ratio
- 19.06
- EPS
- 5.08
- Book Value
- 74.85
- P/B Ratio
- 1.29
- ROE
- 5.39%
- ROCE
- 5.18%
- Debt / Equity
- 1.01
- Net Margin
- 3.86%
- Revenue Growth
- -6.65%
- Profit Growth
- -6.64%
- Dividend Yield
- —
- 52W High
- ₹135.25
- 52W Low
- ₹69.70
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Godavari Drugs Limited
Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.
- Headquarters
- Secunderabad, India
- Promoter Holding
- 54.33%
The full Godavari Drugs Limited analysis
Create a free account to open the complete GODAVARI deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.